Nanalysis Scientific Corp. NSCIF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 29.20M | 29.10M | 28.70M | 29.82M | 30.83M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 29.20M | 29.10M | 28.70M | 29.82M | 30.83M |
| Cost of Revenue | 22.07M | 22.12M | 21.58M | 21.79M | 22.07M |
| Gross Profit | 7.13M | 6.98M | 7.12M | 8.04M | 8.76M |
| SG&A Expenses | 6.00M | 6.90M | 7.23M | 7.69M | 8.08M |
| Depreciation & Amortization | 2.19M | 2.30M | 2.28M | 2.69M | 2.89M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.68M | 31.69M | 31.40M | 32.51M | 33.41M |
| Operating Income | -1.48M | -2.60M | -2.70M | -2.68M | -2.58M |
| Income Before Tax | -3.02M | -4.08M | -4.04M | -8.85M | -8.98M |
| Income Tax Expenses | 11.90K | 3.90K | 12.40K | 4.60K | -4.80K |
| Earnings from Continuing Operations | -3.03 | -4.08 | -4.06 | -8.86 | -8.97 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.03M | -4.08M | -4.06M | -8.86M | -8.97M |
| EBIT | -1.48M | -2.60M | -2.70M | -2.68M | -2.58M |
| EBITDA | -518.00K | -1.52M | -1.09M | -1.00M | -137.70K |
| EPS Basic | -0.02 | -0.03 | -0.04 | -0.08 | -0.08 |
| Normalized Basic EPS | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Diluted | -0.03 | -0.04 | -0.04 | -0.08 | -0.08 |
| Normalized Diluted EPS | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 507.45M | 482.47M | 458.81M | 454.72M | 453.00M |
| Average Diluted Shares Outstanding | 507.45M | 482.47M | 458.81M | 454.72M | 453.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |